PGK1 and thyroid gland papillary carcinoma: Experimental data suggest that PTCSC3 has antitumor properties, as its overexpression inhibits thyroid papillary carcinoma cell proliferation and development in vitro and in vivo by suppressing glycolysis and promoting PGK1 ubiquitin-mediated degradation [70].